Welcome to the CRMD board! Fully dilluted, I got them at around 129M. Includes all outstanding options, warrants, and conversion of other series of stock into common shares. I think the number you were looking at didn't include the conversions of series C,D,E,F shares mostly held by Elliot. This is probably a little high as they have warrants as high as $7 I am including....but you never know and I took everything into account. The huge spike you refer to is 2 fold. Fewer OS and buyiut talks.... Rumor is Elliot and CRMD was looking for a buyer. Still, if memory serves, the MC was up around 250M+ at the time. Either way, it didn't pan out. Plenty of buyers, just not high enough.... Since then, bad double warrant financing followed by pH. 3 delay due to CRO foul up resulted in decline. I actually see no reason by a $2B buyout isn't possible, but only if FDA goes along with DSMB (which they tend to do). Financing is the issue right now. They got an existing ATM they use sparingly and .75 warrants with an exercise date if 9/10. Most are held by insiders and Elliot which lessons the shorting risk - if exercised (and I believe a few were after the pop to .8 from my sources), would be at least some funding but would cause some resistance. Personally, I think BO in next 6 months if FDA stuff all goes as planned and I think it could be big. If they need capital, may do a 1:5 R/S with small raise. Either PO or DO....either way, Elliot will somehow be involved. Basically, huge possible winner, but don't overlook the risk. These are my opinions only with a lot of speculation. Good luck to you!
News 
Market Data 
Discover 
